Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity [Yahoo! Finance]
Zomedica Corp. Common Shares (ZOM)
US:NYSE Investor Relations:
investors.zomedica.com
Company Research
Source: Yahoo! Finance
the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the first quarter ended March 31, 2024. 2024 First Quarter Financial Highlights Revenue for the first quarter of 2024 grew 14% to $6.3 million, compared to first quarter 2023 revenue, driven by 9% growth over the prior year in the Therapeutic Devices segment and 86% growth over the prior year in the Diagnostics segment. Consumable revenues grew to $4.0 million, up 7% over first quarter 2023 revenues of $3.8 million, and represent 64% of total sales. Capital revenues grew to $2.2 million, up 30% over first quarter 2023 revenues of $1.7 million. Gross margin was 66% for the first quarter of 2024. Total cash used during the quarter was $9.6 million. When adjusted for non-recurring one-time items, our non-GAAP operating burn was approximately $4.4 million, in line with first quarter expectatio
Show less
Read more
Impact Snapshot
Event Time:
ZOM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZOM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZOM alerts
High impacting Zomedica Corp. Common Shares news events
Weekly update
A roundup of the hottest topics
ZOM
News
- Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) PlatformAccesswire
- Zomedica Corp. (AMEX:ZOM) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in LiquidityAccesswire
- Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024 [Yahoo! Finance]Yahoo! Finance
- Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024Accesswire
ZOM
Earnings
- 8/10/23 - Miss
ZOM
Sec Filings
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- 5/15/24 - Form 4
- ZOM's page on the SEC website